Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bern Daily Press.
Press releases published on September 22, 2025
Lu Alleruzzo Steps Down as CEO of Immunophotonics After 15 Years, Leadership Transition to New CEO & President Announced
ST. LOUIS, MO, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- Immunophotonics, a clinical-stage biotechnology company focused on developing novel immune-stimulating drugs to augment routine tumor destruction techniques, has announced that Lu …
Atlas Power and Sovereign Digital Infrastructure Execute MOU to Advance Domestic Canadian AI Data Center Infrastructure
Partnership to Deliver Sustainable, AI-Ready Power and Data Infrastructure Across North America ABBOTSFORD, BC, CANADA, September 22, 2025 /EINPresswire.com/ -- Atlas Power Technologies Inc. (“Atlas”), a leader in advanced supercapacitor energy storage, …
The ECO Channel Partners Once Again with CC-Forum for Zurich 2025
HALLANDALE, FL, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- The ECO Channel is proud to announce its continued partnership with the CC-Forum: Investment in Sustainable Development, taking place in Zurich September 28 - October 1st 2025. This …
OutIn präsentiert Mino: Die kleinste tragbare Espressomaschine der Welt
BERLIN, GERMANY, September 22, 2025 /EINPresswire.com/ -- OutIn, die Pioniermarke, die den mobilen Kaffeegenuss neu definiert, stellt heute ihr neuestes Highlight vor: Mino, die bislang kleinste tragbare Espressomaschine der Welt. Entwickelt für …
Apex Invest Digital reveals new eBook on the future of global payments
SWITZERLAND, September 22, 2025 /EINPresswire.com/ -- Ahead of its inaugural Apex Invest Digital event on September 22, 2025, at the Lausanne Palace, Apex Invest has unveiled a comprehensive new ebook designed to guide institutional investors through the …
STMicroelectronics joins FiRa board, strengthening commitment to UWB ecosystem and automotive Digital Key adoption
STMicroelectronics joins FiRa board, strengthening commitment to UWB ecosystem and automotive Digital Key adoption Geneva, Switzerland, September 22, 2025 -- STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the …
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics …
Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research
BOSTON and ZUERICH, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Biognosys, a pioneer in next-generation proteomics services and software, today announced the expansion of its contract research organization (CRO) services to include quantitative …
Veezoo raises $6 million Series A led by ACE Ventures to scale its Agentic Analytics platform globally
The funding, led by ACE Ventures, will accelerate expansion in Europe and the United States. Notable investors include former Tableau CEO Mark Nelson and Ted Kummert, data analytics veteran and former Chief Product Development Officer at UiPath. ZURICH, …
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 59,454 IPC common shares (ISIN: CA46016U1084) during the period of …
Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
ZUG, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today …
Opterion Health AG reicht Antrag auf klinische Studie für die erste Anwendung von OPT101 bei Patienten mit fortgeschrittener chronischer Nierenerkrankung ein
MUTTENZ, Schweiz, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Die Opterion Health AG, ein biopharmazeutisches Unternehmen im klinischen Stadium, das OPT101 als innovative Behandlung für Patienten unter Peritonealdialyse (PD) entwickelt, gab heute die Einreichung …
International Petroleum Corporation to Arrange Fixed Income Investor Meetings
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation ("IPC" or the "Corporation") (TSX, Nasdaq Stockholm: IPCO) announces that it is planning to arrange fixed income investor meetings in connection with a potential issuance of …